Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer

Overview of attention for article published in Drug Design, Development and Therapy, August 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 1 X user

googleplus: 1 Google+ user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 10 Oct 2013

Abstract: Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer characterized by ... Abstract: Small-cell…